ロード中...
Galantamine potentiates the neuroprotective effect of memantine against NMDA-induced excitotoxicity
The combination of memantine, an N-methyl-d-aspartate (NMDA) receptor antagonist, with an acetylcholinesterase inhibitor (AChEI) is the current standard of care in Alzheimer's disease (AD). Galantamine, an AChEI currently marketed for the treatment of AD, exerts memory-enhancing and neuroprotec...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Blackwell Publishing Ltd
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3607148/ https://ncbi.nlm.nih.gov/pubmed/23532860 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.118 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|